CDG Care
Non-Profit & Charitable Organizations · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 38832, Colorado Springs, Colorado...Phone Number
(866) 295-7910Website
www.cdgcare.orgRevenue
<$5 MillionIndustry
About CDG Care
Is CDG Care your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when CDG Care launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once CDG Care has new funding data
Congratulate Masked Content for being promoted to Masked Content at CDG Care
Click to see if CDG Care had a recent Job posting/layoffs
Check if CDG Care has recently received funding, and reach out quickly before it becomes old news!
Check out if CDG Care is spiking on competitors!
Earning: See what the market has to say on CDG Care recently announced quarterly report
CDG Care, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at CDG Care
Find 3 more new buyers
Compare Similar Companies to CDG Care
Compare insights from companies similar to CDG Care, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CDG Care
Company Profile Activity
Activity Insights
CDG Care is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
CDG Care is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about CDG Care.
CDG Care Tech Stack
A closer look at the technologies used by CDG Care
CDG Care News & Media
Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation
BALTIMORE, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in pediatrics and neurology, announced today that it has submitted to the U.S. Food and Drug Administration (FDA) three Orphan Drug Designation (ODD) Requests for substrate replacement therapies to treat ultra-rare inherited metabolic disorders known as Congenital Disorders of GlycosylatiCerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation
BALTIMORE, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in pediatrics and neurology, announced today that it has submitted to the U.S. Food and Drug Administration (FDA) three Orphan Drug Designation (ODD) Requests for substrate replacement therapies to treat ultra-rare inherited metabolic disorders known as Congenital Disorders of Glycosylati
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CDG Care
CDG Care is dedicated to raising awareness, supporting families, and funding research for Congenital Disorders of Glycosylation (CDG), a rare inherited metabolic disorder. The organization connects families, researchers, and clinicians through events like the CDG Scientific & Family Conference, fostering community and collaboration. They provide re... Read More